51 related articles for article (PubMed ID: 11504519)
21. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
[TBL] [Abstract][Full Text] [Related]
22. Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.
Seo HY; Kim DS; Choi YS; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Cancer Chemother Pharmacol; 2009 Feb; 63(3):433-9. PubMed ID: 18398608
[TBL] [Abstract][Full Text] [Related]
23. Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study.
Burch PA; Block M; Schroeder G; Kugler JW; Sargent DJ; Braich TA; Mailliard JA; Michalak JC; Hatfield AK; Wright K; Kuross SA
Clin Cancer Res; 2000 Sep; 6(9):3486-92. PubMed ID: 10999733
[TBL] [Abstract][Full Text] [Related]
24. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
26. [Comparison between intraperitoneal and intravenous 5-fluorouracil administration using pancreatic cancer model of nude mouse].
Maruyama M; Yuasa Y; Endo M
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1785-8. PubMed ID: 9382533
[TBL] [Abstract][Full Text] [Related]
27. [Does locoregional chemotherapy improve survival in patients with non-resectable pancreatic carcinoma? Results of an open controlled study].
Falconi M; Sartori N; Cantore M; Salvia R; Talamini G; Bassi C; Smerieri F; Pederzoli P
Chir Ital; 2001; 53(1):23-32. PubMed ID: 11280825
[TBL] [Abstract][Full Text] [Related]
28. [Locoregional and systemic therapy of advanced pancreatic carcinoma].
Gebauer T; Ridwelski K; Fahlke J; Lippert H
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1344-7. PubMed ID: 9931877
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic cancer therapy with a novel pump for controlled drug release.
Haramoto M; Kohno M; Nakajima O; Horibe T; Kiyohara M; Fukazawa H; Togawa T; Kawakami K
Oncol Rep; 2010 Feb; 23(2):365-70. PubMed ID: 20043096
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growth.
Liu CD; Rongione AJ; Garvey L; Balasubramaniam A; McFadden DW
Am J Surg; 1996 Jan; 171(1):192-6. PubMed ID: 8554139
[TBL] [Abstract][Full Text] [Related]
31. [Clinical evaluation of neocarzinostatin in digestive system cancer. 2. Clinical studies on the administration of neocarzinostatin in advanced and recurrent carcinoma of the pancreas].
Kikuchi K; Kusama S; Furue H; Muto T; Toriyama K; Wakiya M
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1872-7. PubMed ID: 6224466
[TBL] [Abstract][Full Text] [Related]
32. Palliative and adjuvant regional chemotherapy in pancreatic cancer.
Link KH; Gansauge F; Görich J; Leder GH; Rilinger N; Beger HG
Eur J Surg Oncol; 1997 Oct; 23(5):409-14. PubMed ID: 9393568
[TBL] [Abstract][Full Text] [Related]
33. Celiac axis infusion chemotherapy in advanced nonresectable pancreatic cancer.
Maurer CA; Borner MM; Läuffer J; Friess H; Z'graggen K; Triller J; Büchler MW
Int J Pancreatol; 1998 Jun; 23(3):181-6. PubMed ID: 9629517
[TBL] [Abstract][Full Text] [Related]
34. Results of regional chemotherapy using the aortic stop-flow technique in advanced pancreatic carcinoma.
Meyer F; Gebauer T; Grote R; Martens-Lobenhoffer J; Ridwelski K; Lippert H
Surg Today; 2006; 36(2):155-61. PubMed ID: 16440163
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinoma.
Öman M; Wettergren Y; Odin E; Westermark S; Naredi P; Hemmingsson O; Taflin H
Cancer Chemother Pharmacol; 2021 Oct; 88(4):619-631. PubMed ID: 34132895
[TBL] [Abstract][Full Text] [Related]
36. [Portal blood levels of 5-FU administered intraperitoneally].
Kakizaki K; Teshima S; Yamauchi H
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1631-3. PubMed ID: 8373235
[TBL] [Abstract][Full Text] [Related]
37. Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis.
Graversen M; Detlefsen S; Bjerregaard JK; Fristrup CW; Pfeiffer P; Mortensen MB
Ther Adv Med Oncol; 2018; 10():1758835918777036. PubMed ID: 29899763
[TBL] [Abstract][Full Text] [Related]
38. Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Graversen M; Detlefsen S; Bjerregaard JK; Pfeiffer P; Mortensen MB
Clin Exp Metastasis; 2017 Jun; 34(5):309-314. PubMed ID: 28516306
[TBL] [Abstract][Full Text] [Related]
39. Treatment of non-resectable pancreatic cancer with intraperitoneal 5-FU and leucovorin IV.
Oman M; Blind PJ; Naredi P; Gustavsson B; Hafström LO
Eur J Surg Oncol; 2001 Aug; 27(5):477-81. PubMed ID: 11504519
[TBL] [Abstract][Full Text] [Related]
40. Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancer.
Oman M; Lundqvist S; Gustavsson B; Hafström LO; Naredi P
Cancer Chemother Pharmacol; 2005 Dec; 56(6):603-9. PubMed ID: 16047145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]